Notably, ICAM-1 overexpression has been associated with more aggressive tumor phenotypes and poor prognosis in different types of malignancies, including multiple myeloma [19], breast cancer [20], gastric cancer [21], liver cancer [22], and pancreatic cancer [23]. Here, ICAM1 is linked to liver cancer.